Application 021488

Type
NDA
Sponsor
TOLMAR THERAP

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001ELIGARDLEUPROLIDE ACETATEINJECTABLE;SUBCUTANEOUS30MG/VIALYesYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
62935-302ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent

Documents

DocumentSubmission typeDate
85889SUPPL 2026-05-12
85854SUPPL 2026-05-08
81371SUPPL 2025-02-25
81346SUPPL 2025-02-25
81015SUPPL 2025-02-06
80965SUPPL 2025-02-06
78531SUPPL 2024-05-22
78530SUPPL 2024-05-22
77295SUPPL 2024-01-25
77287SUPPL 2024-01-24
74862SUPPL 2023-07-21
74861SUPPL 2023-07-21
74852SUPPL 2023-07-21
74851SUPPL 2023-07-21
57735SUPPL2019-02-21
57698SUPPL2019-02-19
37058SUPPL2016-03-03
5526SUPPL2016-03-02
37057SUPPL2014-10-15
5525SUPPL2014-10-14
27921SUPPL2013-03-01
15589SUPPL2013-03-01
23667ORIG2011-12-20
27920SUPPL2011-04-11
15588SUPPL2011-04-11
27919SUPPL2011-01-20
15587SUPPL2011-01-20
27918SUPPL2010-10-13
15586SUPPL2010-10-12
5524SUPPL2007-11-19
37056SUPPL2007-11-13
27917ORIG2004-06-03
5523SUPPL2004-01-14
21688ORIG2003-05-08
37055ORIG2003-02-13